HBSC - President kauft 714,286 Aktien !!! - 500 Beiträge pro Seite
eröffnet am 04.08.06 08:44:11 von
neuester Beitrag 04.08.06 14:32:44 von
neuester Beitrag 04.08.06 14:32:44 von
Beiträge: 17
ID: 1.074.991
ID: 1.074.991
Aufrufe heute: 0
Gesamt: 1.325
Gesamt: 1.325
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| gestern 21:53 | 122 | |
| gestern 19:23 | 114 | |
| vor 55 Minuten | 108 | |
| gestern 22:47 | 97 | |
| 18.09.18, 18:46 | 83 | |
| gestern 18:00 | 80 | |
| gestern 23:32 | 77 | |
| 08.09.13, 17:52 | 61 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.050,00 | +0,06 | 48 | |||
| 2. | 2. | 0,1855 | -1,85 | 48 | |||
| 3. | 3. | 0,1300 | 0,00 | 23 | |||
| 4. | 4. | 178,01 | -2,44 | 21 | |||
| 5. | 6. | 8,4175 | +0,15 | 19 | |||
| 6. | 5. | 3,4900 | +0,14 | 18 | |||
| 7. | 10. | 36,45 | 0,00 | 16 | |||
| 8. | 8. | 6,8180 | +0,07 | 16 |
Feedback
http://www.sec.gov/Archives/edgar/data/1070181/0001091818060… 
Der Newsflow war in den letzten Tagen hervorragend
Thu, Aug 03, 2006
9:43 AM HBSC Continues Momentum: Is Granted Its Fourth Patent From the U.S. Patent Office! August 3, 2006 - Market Wire
9:08 AM Stock Watch: Small Public Company Has Been Granted Its Fourth Patent From the U.S. Patent Office! August 3, 2006 - Market Wire
7:00 AM Human BioSystems, Inc. CEO Featured in Exclusive Interview With WallSt.net - PR Newswire
Wed, Aug 02, 2006
4:05 PM Human BioSystems Granted Their 4th U.S. Patent: #7,083,910 "Preservation of Blood Platelets with Citrate" - Market Wire
Fri, Jul 28, 2006
9:43 AM Stock on the Move: HBSC Looks to Enter the Bio Energy Field; Signs Letter of Intent to Acquire Ethanol Projects! July 28, 2006 - Market Wire
9:40 AM Market News First (mn1.com) to Interview Harry Masuda, CEO of Human BioSystems on HBSC's Breaking News - Business Wire
FILING Report of unscheduled material events or corporate changes - Form 8-K
Thu, Jul 27, 2006
4:05 PM Breaking News: Human BioSystems Signs Letter of Intent to Acquire Ethanol Projects - Market Wire
Mon, Jul 24, 2006
2:03 PM Harry Masuda, CEO of Human BioSystems, to be Interviewed by Market News First Radio (MN1.com) - Business Wire
Kursziel 0,30$
Der Newsflow war in den letzten Tagen hervorragend
Thu, Aug 03, 2006
9:43 AM HBSC Continues Momentum: Is Granted Its Fourth Patent From the U.S. Patent Office! August 3, 2006 - Market Wire
9:08 AM Stock Watch: Small Public Company Has Been Granted Its Fourth Patent From the U.S. Patent Office! August 3, 2006 - Market Wire
7:00 AM Human BioSystems, Inc. CEO Featured in Exclusive Interview With WallSt.net - PR Newswire
Wed, Aug 02, 2006
4:05 PM Human BioSystems Granted Their 4th U.S. Patent: #7,083,910 "Preservation of Blood Platelets with Citrate" - Market Wire
Fri, Jul 28, 2006
9:43 AM Stock on the Move: HBSC Looks to Enter the Bio Energy Field; Signs Letter of Intent to Acquire Ethanol Projects! July 28, 2006 - Market Wire
9:40 AM Market News First (mn1.com) to Interview Harry Masuda, CEO of Human BioSystems on HBSC's Breaking News - Business Wire
FILING Report of unscheduled material events or corporate changes - Form 8-K
Thu, Jul 27, 2006
4:05 PM Breaking News: Human BioSystems Signs Letter of Intent to Acquire Ethanol Projects - Market Wire
Mon, Jul 24, 2006
2:03 PM Harry Masuda, CEO of Human BioSystems, to be Interviewed by Market News First Radio (MN1.com) - Business Wire
Kursziel 0,30$
Komisch die meldung ist jetzt 2 Tage alt und kein schwein reagiert darauf. Human Bio ist mit neuen Patenten am Werk, leute die nicht kaufen werden sich umsehen. Kurs nächste Woche bei guten 0,55 Euro nsch meiner meinung. 
Antwort auf Beitrag Nr.: 23.312.457 von Gismo37 am 04.08.06 09:09:41In den nächsten Tagen sollte eine oder mehrere Kaufempfehlungen von analysten eintrudeln 
Gut möglich, dass HBSC dann richtig durchstartet und bis 1,-$ hochläuft
Gut möglich, dass HBSC dann richtig durchstartet und bis 1,-$ hochläuft
HBSC steigt sogar in Ethanol ein
July 27, 2006 - 4:05 PM EDT
Breaking News: Human BioSystems Signs Letter of Intent to Acquire Ethanol Projects
Human BioSystems ("HBS") (OTCBB: HBSC), a developer of preservation platforms for organs and other biomaterials, announced today that it has signed a letter of intent ("LOI") to acquire two ethanol production facility projects from EXL III Group Corporation ("EXL III"), an equity partner in ethanol plant ventures. HBS will also enlist the services of Claude Luster III, the principal of EXL III Group Corporation, to serve as the President of a new subsidiary to be formed to develop the ethanol business.
The LOI provides that HBS will acquire the projects from EXL III Group Corporation for restricted HBS common stock. In addition, HBS will enter into a Consulting Services Agreement with Mr. Luster.
"We made the decision to enter the bio energy field because it gives HBS the potential to achieve substantial revenue and profit growth within a predictable timetable, and because the opportunity and expertise to pursue the renewable energy market exists with this acquisition," stated Harry Masuda, CEO of Human BioSystems. "This acquisition should give HBS additional financing options not previously available," continued Mr. Masuda.
The acquisition, which is expected to close in the fall of 2006, is subject to certain conditions, including but not limited to completion of satisfactory due diligence by HBS, the negotiation and completion of a definitive acquisition agreement and Consulting Services Agreement, approval of the HBS and EXL III boards of directors and other customary conditions.
HBS is headquartered in Palo Alto, California with research facilities in Michigan.
Certain statements contained herein are "forward-looking'' statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, failure to complete a final definitive agreement, failure to obtain regulatory approvals for the construction of ethanol plants, failure to obtain the required financing and to construct the ethanol plants, failure of the ethanol plants to meet standards, the inability to find raw material for the production of ethanol or to sell the ethanol at on acceptable terms, the risks involved in pursuing a business unrelated to HBS' prior business, and other factors discussed in filings made by the Company with the Securities and Exchange Commission
Source: Market Wire (July 27, 2006 - 4:05 PM EDT)
July 27, 2006 - 4:05 PM EDT
Breaking News: Human BioSystems Signs Letter of Intent to Acquire Ethanol Projects
Human BioSystems ("HBS") (OTCBB: HBSC), a developer of preservation platforms for organs and other biomaterials, announced today that it has signed a letter of intent ("LOI") to acquire two ethanol production facility projects from EXL III Group Corporation ("EXL III"), an equity partner in ethanol plant ventures. HBS will also enlist the services of Claude Luster III, the principal of EXL III Group Corporation, to serve as the President of a new subsidiary to be formed to develop the ethanol business.
The LOI provides that HBS will acquire the projects from EXL III Group Corporation for restricted HBS common stock. In addition, HBS will enter into a Consulting Services Agreement with Mr. Luster.
"We made the decision to enter the bio energy field because it gives HBS the potential to achieve substantial revenue and profit growth within a predictable timetable, and because the opportunity and expertise to pursue the renewable energy market exists with this acquisition," stated Harry Masuda, CEO of Human BioSystems. "This acquisition should give HBS additional financing options not previously available," continued Mr. Masuda.
The acquisition, which is expected to close in the fall of 2006, is subject to certain conditions, including but not limited to completion of satisfactory due diligence by HBS, the negotiation and completion of a definitive acquisition agreement and Consulting Services Agreement, approval of the HBS and EXL III boards of directors and other customary conditions.
HBS is headquartered in Palo Alto, California with research facilities in Michigan.
Certain statements contained herein are "forward-looking'' statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, failure to complete a final definitive agreement, failure to obtain regulatory approvals for the construction of ethanol plants, failure to obtain the required financing and to construct the ethanol plants, failure of the ethanol plants to meet standards, the inability to find raw material for the production of ethanol or to sell the ethanol at on acceptable terms, the risks involved in pursuing a business unrelated to HBS' prior business, and other factors discussed in filings made by the Company with the Securities and Exchange Commission
Source: Market Wire (July 27, 2006 - 4:05 PM EDT)
Trading Spotlight
HBSC steigt sogar in Ethanol ein
July 27, 2006 - 4:05 PM EDT
Breaking News: Human BioSystems Signs Letter of Intent to Acquire Ethanol Projects
Human BioSystems ("HBS") (OTCBB: HBSC), a developer of preservation platforms for organs and other biomaterials, announced today that it has signed a letter of intent ("LOI") to acquire two ethanol production facility projects from EXL III Group Corporation ("EXL III"), an equity partner in ethanol plant ventures. HBS will also enlist the services of Claude Luster III, the principal of EXL III Group Corporation, to serve as the President of a new subsidiary to be formed to develop the ethanol business.
The LOI provides that HBS will acquire the projects from EXL III Group Corporation for restricted HBS common stock. In addition, HBS will enter into a Consulting Services Agreement with Mr. Luster.
"We made the decision to enter the bio energy field because it gives HBS the potential to achieve substantial revenue and profit growth within a predictable timetable, and because the opportunity and expertise to pursue the renewable energy market exists with this acquisition," stated Harry Masuda, CEO of Human BioSystems. "This acquisition should give HBS additional financing options not previously available," continued Mr. Masuda.
The acquisition, which is expected to close in the fall of 2006, is subject to certain conditions, including but not limited to completion of satisfactory due diligence by HBS, the negotiation and completion of a definitive acquisition agreement and Consulting Services Agreement, approval of the HBS and EXL III boards of directors and other customary conditions.
HBS is headquartered in Palo Alto, California with research facilities in Michigan.
Certain statements contained herein are "forward-looking'' statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, failure to complete a final definitive agreement, failure to obtain regulatory approvals for the construction of ethanol plants, failure to obtain the required financing and to construct the ethanol plants, failure of the ethanol plants to meet standards, the inability to find raw material for the production of ethanol or to sell the ethanol at on acceptable terms, the risks involved in pursuing a business unrelated to HBS' prior business, and other factors discussed in filings made by the Company with the Securities and Exchange Commission
Source: Market Wire (July 27, 2006 - 4:05 PM EDT)
July 27, 2006 - 4:05 PM EDT
Breaking News: Human BioSystems Signs Letter of Intent to Acquire Ethanol Projects
Human BioSystems ("HBS") (OTCBB: HBSC), a developer of preservation platforms for organs and other biomaterials, announced today that it has signed a letter of intent ("LOI") to acquire two ethanol production facility projects from EXL III Group Corporation ("EXL III"), an equity partner in ethanol plant ventures. HBS will also enlist the services of Claude Luster III, the principal of EXL III Group Corporation, to serve as the President of a new subsidiary to be formed to develop the ethanol business.
The LOI provides that HBS will acquire the projects from EXL III Group Corporation for restricted HBS common stock. In addition, HBS will enter into a Consulting Services Agreement with Mr. Luster.
"We made the decision to enter the bio energy field because it gives HBS the potential to achieve substantial revenue and profit growth within a predictable timetable, and because the opportunity and expertise to pursue the renewable energy market exists with this acquisition," stated Harry Masuda, CEO of Human BioSystems. "This acquisition should give HBS additional financing options not previously available," continued Mr. Masuda.
The acquisition, which is expected to close in the fall of 2006, is subject to certain conditions, including but not limited to completion of satisfactory due diligence by HBS, the negotiation and completion of a definitive acquisition agreement and Consulting Services Agreement, approval of the HBS and EXL III boards of directors and other customary conditions.
HBS is headquartered in Palo Alto, California with research facilities in Michigan.
Certain statements contained herein are "forward-looking'' statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, failure to complete a final definitive agreement, failure to obtain regulatory approvals for the construction of ethanol plants, failure to obtain the required financing and to construct the ethanol plants, failure of the ethanol plants to meet standards, the inability to find raw material for the production of ethanol or to sell the ethanol at on acceptable terms, the risks involved in pursuing a business unrelated to HBS' prior business, and other factors discussed in filings made by the Company with the Securities and Exchange Commission
Source: Market Wire (July 27, 2006 - 4:05 PM EDT)
Shares Outstanding: 64.19M
Float: 46.48M
Float: 46.48M
Antwort auf Beitrag Nr.: 23.312.749 von Graffy am 04.08.06 09:28:00Chart ist vom April, Aktienstand heute:
Shares Outstanding: 68.58M
Float: 49.92M
Shares Outstanding: 68.58M
Float: 49.92M
Antwort auf Beitrag Nr.: 23.312.749 von Graffy am 04.08.06 09:28:00Charttechnisch sollte HBSC kurzfristig bis 0,35$ 
laufen.
laufen.
Gute Aktie, sehr gute Aktie
Wir sollten die 1€ wieder sehen
Wir sollten die 1€ wieder sehen
Antwort auf Beitrag Nr.: 23.314.046 von Montypower am 04.08.06 10:41:57Ich bin ja schon froh wenn ich meinen Einstand von 0,48346 wiederbekomme.....
Antwort auf Beitrag Nr.: 23.314.096 von malteser80 am 04.08.06 10:44:41autsch
also da habe ich mich doch erheblich günstiger eingekauft
also da habe ich mich doch erheblich günstiger eingekauft
4 Patente, die Insider kaufen und bald Ethanol im Boot
Strong Buy!
Strong Buy!
Ich schätze, dass wir es heute oder am Montag mit so einer Kurs-Reaktion wie Ende August letztes Jahr zu tun haben werden
OTCPicks.com: Daily Market Movers Digest Stock Alerts, Friday, August 4th, HBSC, EPLJ, AFVS, ENSY, GNOLF
Aug 04, 2006 (M2 PRESSWIRE via COMTEX) -- Today our stock watch alerts today include stock alerts for Human Biosystems, Inc. (OTCBB: HBSC), Horizon Networks, Inc. (OTC: EPLJ), AFV Solutions, Inc. (OTCBB: AFVS), eNotes Systems, Inc (OTCBB: ENSY), and Genoil Inc (OTCBB: GNOLF)
OTC STOCK ALERTS
HUMAN BIOSYSTEMS, INC. (OTCBB: HBSC) "Up 7.78% at close on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/HBSC.php
Human Biosystems, Inc. (OTCBB: HBSC), a development stage company, engages in the development of preservation platforms for organs and other biomaterials. The company is developing proprietary above zero (HBS-AZ) and below zero (HBS-BZ) organ and issue preservation systems and methods for preserving platelets, red blood cells, heart valves, tissues, and organs. Its technologies would extend the shelf life of blood platelets and other biological material. The company's target customers include blood banks, hospitals, clinics, and similar organizations. It operates in the United States and Russia. Human BioSystems was founded in 1998 under the name HyperBaric Systems and changed its name to Human BioSystems, Inc. in 2002. The company is based in Palo Alto, California.
HBSC News:
August 3 - Human BioSystems, Inc. CEO Featured in Exclusive Interview With WallSt.net
On July 27, Harry Masuda, CEO of Human BioSystems, Inc. (OTC Bulletin Board: HBSC) updated the investment community in an exclusive interview with www.wallst.net Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, upcoming strategic and financial milestones.
To hear the interview in its entirety, visit www.wallst.net , and click on "Interviews." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the respective company's ticker symbol in the Search Archive window.
Aug 04, 2006 (M2 PRESSWIRE via COMTEX) -- Today our stock watch alerts today include stock alerts for Human Biosystems, Inc. (OTCBB: HBSC), Horizon Networks, Inc. (OTC: EPLJ), AFV Solutions, Inc. (OTCBB: AFVS), eNotes Systems, Inc (OTCBB: ENSY), and Genoil Inc (OTCBB: GNOLF)
OTC STOCK ALERTS
HUMAN BIOSYSTEMS, INC. (OTCBB: HBSC) "Up 7.78% at close on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/HBSC.php
Human Biosystems, Inc. (OTCBB: HBSC), a development stage company, engages in the development of preservation platforms for organs and other biomaterials. The company is developing proprietary above zero (HBS-AZ) and below zero (HBS-BZ) organ and issue preservation systems and methods for preserving platelets, red blood cells, heart valves, tissues, and organs. Its technologies would extend the shelf life of blood platelets and other biological material. The company's target customers include blood banks, hospitals, clinics, and similar organizations. It operates in the United States and Russia. Human BioSystems was founded in 1998 under the name HyperBaric Systems and changed its name to Human BioSystems, Inc. in 2002. The company is based in Palo Alto, California.
HBSC News:
August 3 - Human BioSystems, Inc. CEO Featured in Exclusive Interview With WallSt.net
On July 27, Harry Masuda, CEO of Human BioSystems, Inc. (OTC Bulletin Board: HBSC) updated the investment community in an exclusive interview with www.wallst.net Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, upcoming strategic and financial milestones.
To hear the interview in its entirety, visit www.wallst.net , and click on "Interviews." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the respective company's ticker symbol in the Search Archive window.
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 49 | ||
| 47 | ||
| 21 | ||
| 20 | ||
| 19 | ||
| 18 | ||
| 16 | ||
| 16 | ||
| 15 | ||
| 13 |
| Wertpapier | Beiträge | |
|---|---|---|
| 11 | ||
| 10 | ||
| 10 | ||
| 9 | ||
| 9 | ||
| 9 | ||
| 9 | ||
| 8 | ||
| 7 | ||
| 7 |
